Crowdonomics
All companies

DOC.COM INC.

Opening soonOperating

Software & AI · New York, NY

DOC.COM runs a telehealth platform that connects patients with licensed physicians, psychologists and veterinarians, with an online marketplace for over-the-counter products and prescriptions. Its pharmacy unit fills and ships prescriptions nationwide, and it offers a free first consultation and live streams by licensed professionals.

Opening soonOffering coming soon

Not yet accepting investment.

See the round
Estimated pre-money ⓘ
$1.52B
As of Mar 2026 · from Reg A Offering (2026) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$11,933,560
Crowd $45K · Private $11.9M · 9 rounds since 2022
Latest share price
$8.00
Reg A+ · Equity · Mar 2026 offering price

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$0
−$1.1M
2022
−$1.4M
2023
$13.2M
−$19.1M
2024
$6.8M
−$69.0M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
—
$13,174,729
$6,820,552
Cost of goods sold
$0
—
$5,281,182
$7,912,498
Gross margin
—
—
60%
-16%
Net income
-$1,080,628
-$1,414,898
-$19,069,195
-$69,034,984
Balance sheet
Cash
$397
$664
$2,199,291
$799,403
Accounts receivable
$0
—
$3,631,814
$1,946,631
Total assets
$49,700
$65,664
$118,502,732
$70,339,616
Long-term debt
$642,178
—
$10,254,135
$10,448,850
Total liabilities
$289,660
$1,005,680
$84,874,071
$84,568,494
Other
Headcount
8
—
350
8

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$1.7M
est. pre-money
$693.0M
est. pre-money
$588.8M
est. pre-money
$302K
est. pre-money
$1.52B
est. pre-money
Reg D · Class A Common · Dec 2023
Private · Class A Common · Dec 2024
Private · Common · Sep 2025
Reg A+ · Equity · Oct 2023
Reg A+ · Equity · Mar 2026

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Share price over rounds

log scale
$8.00$0.2828$0.01
Oct 2023Mar 2026
Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · Sep 2025 (-27.1%)

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Sep 29, 2026
Class A Common Stock · 92.7%Class B Common Stock · 7.32%
ClassOutstandingVotes / shareShare of totalVotesLast price
Class A Common Stock189,949,992192.7%38.8%$8.00Mar 2026
Class B Common Stock15,000,000207.32%61.2%—
Total204,949,992100%100%

Shares outstanding over timein today's share terms

205M102M0
Oct 2023Sep 2026
Class A Common StockClass B Common StockRound opened

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Sep 29, 2026

  • Charles Nader15,000,000 Class B shares100.0%of Class B shares
  • Charles Nader145,000,003 Class A shares75.9%of Class A shares
  • Jamie Freed8,000,000 Class A shares4.19%of Class A shares
  • Aaron Trager108,000 Class A shares issuable0.06%of Class A shares issuable

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $24MEst. pre-money $1.5B
Raised $1.5MInvestors 3
Raised $45.1K / $250KEst. pre-money $302.4K
Raised $7.3MEst. pre-money $588.8M
Raised $1.6MEst. pre-money $693M
Raised $20.7KEst. pre-money $1.7M
Raised $709.2KInvestors 28

Team

16 people
Charles Nader
President, CEO, Director, Chairman of the Board
Alejandro Ulloa
Chief Financial Officer
Hernan Ramirez
Chief Technology Officer
Ignacio Valencia
Chief Business Development Officer
Itzel Ocampo MD
Chief Science Officer & Director
Jamie Freed
Chief Marketing Officer
Noel Trainor
Chief Operating Officer
Noemi Trainor
Chief Innovation Officer
Rocio Nader
Chief Legal Director
Show 7 more people
Aaron Trager
Head of Pharmacy
Neil Kleinman
Head of Banking
Daniel Fraser
Blockchain Deployment Director
Fernando Braun
Member of Audit Committee
Jose Pablo Chico
Member of Audit Committee
Lesly Kernisant MD
Medical Director US
Sergio del Valle
Chair of Audit Committee

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 1-A/ASep 29, 20260001493152-26-044670
    EDGAR
  • Form 1-SASep 28, 20260001493152-26-044661
    EDGAR
  • Form 1-A/AApr 1, 20260001493152-26-014718
    EDGAR
  • Form 1-AMar 2, 20260001493152-26-008492
    EDGAR
  • Form 253G2Feb 13, 20260001493152-26-006797
    EDGAR
  • Form DFeb 10, 20260001493152-26-005994
    EDGAR
  • Form 1-A POSFeb 4, 20260001493152-26-005000
    EDGAR
  • Form 1-SAFeb 2, 20260001493152-26-004776
    EDGAR
Source: SEC EDGARCIK 0001925674DEShare price $8.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.